Otrivin Plus 0.5 mg/ml + 0.6 mg/m Metered-dose nasal spray, solution. Clear, colourless solution.
PDF Leaflet Revision Date: 23 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of nasal congestion and rhinorrhea in adults.
Dosage (summary)
1 puff in each nostril up to 3 times daily, max 7 days.
Onset of Action / Duration
Onset: 5-10 mins, Duration: 6-8 hours
Special Populations
- Elderly (> 70 years)
- Children under 18
Pregnancy & Breastfeeding
Not proven safe in pregnancy; avoid breastfeeding.
Key Drug Interactions
- MAO inhibitors
- Tri- and tetra-cyclic antidepressants
- Other anticholinergic drugs
Contraindications
- Hypersensitivity to active substances
- Glaucoma
- Rhinitis sicca
- Post-surgical dura mater penetration
Common side effects
- Epistaxis
- Nasal dryness
- Dizziness
- Headache
Counselling Points
- Do not exceed 3 applications daily
- Avoid contact with eyes
- Report any severe side effects
Serious warnings
- Caution in hypertension, cardiovascular diseases
- Risk of rebound congestion with prolonged use
Important Disclaimer
The Otrivin Plus 0.5 mg/ml + 0.6 mg/m Metered-dose nasal spray, solution. Clear, colourless solution. professional information leaflet below is the property of Haleon South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
